Tarveda Therapeutics is a clinical stage biopharmaceutical company developing a new class of potent and selective precision oncology medicines, which it refers to as Pentarin® miniature drug conjugates, for the treatment of patients with various solid tumor malignancies.

Biotechnology

Education

Tarveda Therapeutics

tingting wang

Edward Garmey

Anudeep Polam

The executive team at Tarveda Therapeutics has experience in business development, product development, and strategic planning from companies such as Kadiyala, Johnson & Johnson, and Johnson & Johnson Regenerative Therapeutics. They also have education histories from renowned schools such as Johns Hopkins School of Medicine and Dartmouth College.

CEO and Executive Team

About

Team members

Other teams at Tarveda Therapeutics

Board of Directors

Leadership Team